All Pharma News
After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees

After buying out Flexion for $450M, Pacira quietly lays off 110 of its employees
P. Schloesser ENDPTS
04 Mar 2022
Share Share
Pacira buys Flexion for $450M to boost pain offerings

Pacira buys Flexion for $450M to boost pain offerings
Angus Liu FIERCEPHARMA
12 Oct 2021
Share Share
Supernus and Pacira swoop while their targets are down

Supernus and Pacira swoop while their targets are down
Madeleine Armstrong EVALUATE
11 Oct 2021
Share Share
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635
GLOBENEWSWIRE
01 Oct 2021
Share Share
Flexion Announces Inclusion of ZILRETTA in AAOS Clinical Practice Guidelines

Flexion Announces Inclusion of ZILRETTA in AAOS Clinical Practice Guidelines
GLOBENEWSWIRE
02 Sep 2021
Share Share
Flexion expands P1b Trial in FX301 for the Management of Post-Operative Pain

Flexion expands P1b Trial in FX301 for the Management of Post-Operative Pain
GLOBENEWSWIRE
25 Aug 2021
Share Share
Flexion Therapeutics Reports Second-Quarter 2021 Financial Results

Flexion Therapeutics Reports Second-Quarter 2021 Financial Results
GLOBENEWSWIRE
04 Aug 2021
Share Share
Flexion Therapeutics to Second-Quarter 2021 Financial Results on August 4, 2021

Flexion Therapeutics to Second-Quarter 2021 Financial Results on August 4, 2021
GLOBENEWSWIRE
29 Jul 2021
Share Share
Flexion Announces Appointment of Utpal Koppikar to its Board of Directors

Flexion Announces Appointment of Utpal Koppikar to its Board of Directors
GLOBENEWSWIRE
12 Jul 2021
Share Share
Flexion Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Flexion Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
02 Jul 2021
Share Share